|
LGND Ligand Pharmaceuticals Inc 886163 |
| Balance Sheet |
|
Current Assets
|
$865,415,000.00 |
|
Assets
|
$1,532,105,000.00 |
|
Current Liabilities
|
$40,667,000.00 |
|
Liabilities
|
$534,783,000.00 |
|
Equity
|
$997,322,000.00 |
|
Shares Out
|
20029000.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$48,691,000.00 |
|
Investing Cash Flow
|
$-94,347,000.00 |
| Market Analysis |
Market Cap
|
$5,934,392,410.00 |
|
Price
|
$283.77 |
|
BVPS
|
49.79 |
|
PB
|
5.95 |
|
EPS
|
-0.67 |
|
PE
|
40.89 |
|
PS
|
30.94 |
|
FCF
|
$48,463,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:19 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:13 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-26 |
2.02 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-07 |
1.63 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
1.60 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
3.09 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view LGND documents filed with the SEC.
LGND Filings
Clear
